Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Voršilák2020 - Bayesian estimation of synthetic accessibility of organic compounds

ABSTRACT: SYBA uses a fragment-based approach to classify whether a molecule is easy or hard to synthesize, and it can also be used to analyze the contribution of individual fragments to the total synthetic accessibility. The easy-to-synthesize dataset is an extract of the ZINC purchasable compounds, and the hard-to-synthesize dataset is generated using a Nonpher approach (introducing small molecular perturbations to transform molecules into more complex compounds). The fragments are calculated with ECFP8 descriptors, and independence between fragments is assumed. Model Type: Predictive machine learning model. Model Relevance: Prediction of synthetic accessibility Model Encoded by: Miquel Duran-Frigola (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos7pw8

SUBMITTER: Zainab Ashimiyu-Abdusalam

PROVIDER: MODEL2407180002 | BioModels | 2024-07-18

REPOSITORIES: BioModels

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	MODEL2407180002?filename=BioModelsMetadata%20-%20eos7pw8.csv	Csv

Items per page:

1 - 1 of 1

Publications

SYBA: Bayesian estimation of synthetic accessibility of organic compounds.

Voršilák Milan M Kolář Michal M Čmelo Ivan I Svozil Daniel D

Journal of cheminformatics 20200520 1

SYBA (SYnthetic Bayesian Accessibility) is a fragment-based method for the rapid classification of organic compounds as easy- (ES) or hard-to-synthesize (HS). It is based on a Bernoulli naïve Bayes classifier that is used to assign SYBA score contributions to individual fragments based on their frequencies in the database of ES and HS molecules. SYBA was trained on ES molecules available in the ZINC15 database and on HS molecules generated by the Nonpher methodology. SYBA was compared with a ran ...[more]

PMID: 33431015

Similar Datasets

Pu2019 - eToxPred: an ML-based approach to estimate the toxicity, and synthetic accessibility of drug candidates

Project description:The eToxPred tool has been developed to predict, on one hand, the synthetic accessibility (SA) score, or how easy it is to make the molecule in the laboratory, and, on the other hand, the toxicity (Tox) score, or the probability of the molecule of being toxic to humans. The authors trained and cross-validated both predictors on a large number of datasets, and demonstrated the method usefulness in building virtual custom libraries. Model Type: Predicitive machine learning model. Model Relevance: Predicts Synthetic Accesibility and Toxicity score of a chemical compound Model Encoded by: Miquel Duran-Frigola (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos92sw

2024-07-18 | MODEL2406270007 | BioModels

Pereira2020 - Discovering growth Inhibitors of Neisseria gonorrhoeae with Machine Learning

Project description:The authors curated a dataset of 282 compounds from ChEMBL, of which 160 (56.7%) were labeled as active N. gonorrhoeae inhibitor compounds. They used this dataset to build a naïve Bayesian model and used it to screen a commercial library. With this method,they identified and validated two hits compound. Model Type: Predictive machine learning model. Model Relevance: The model predicts the probability of activity for the inhibition of the Antimicrobial pathogen N. gonorrhoeae. Model Encoded by: Sarima Chiorlu (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos5cl7

2024-05-08 | MODEL2405080003 | BioModels

Ertl2009 - Synthetic accessibility score estimation

Project description:Estimation of synthetic accessibility score (SAScore) of drug-like molecules based on molecular complexity and fragment contributions. The fragment contributions are based on a 1M sample from PubChem and the molecular complexity is based on the presence/absence of non-standard structural features. It has been validated comparing the SAScore and the estimates of medicinal chemist experts for 40 molecules (r2 = 0.89). Model Type: Predictive machine learning model. Model Relevance: Estimation of synthetic accessibility score (SAScore) Model Encoded by: Miquel Duran-Frigola (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos9ei3

2024-07-18 | MODEL2407180004 | BioModels

Sun2017 - predictive and interpretable models for PAMPA permeability 7

Project description:Parallel Artificial Membrane Permeability is an in vitro surrogate to determine the permeability of drugs across cellular membranes. PAMPA at pH 7.4 was experimentally determined in a dataset of 5,473 unique compounds by the NIH-NCATS. 50% of the dataset was used to train a classifier (SVM) to predict the permeability of new compounds, and validated on the remaining 50% of the data, rendering an AUC = 0.88. The Peff was converted to logarithmic, log Peff value lower than 2.0 were considered to have low to moderate permeability, and those with a value higher than 2.5 were considered as high-permeability compounds. Model Type: Predictive machine learning model. Model Relevance: The model predicts a chemical compound as highly or low/moderate permeable. Model Encoded by: Pauline (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos9tyg

2024-04-23 | MODEL2404220001 | BioModels

Williams2022 - Permeable compound selection using in vitro ADME data (PAMPA pH 5).

Project description:Parallel Artificial Membrane Permeability is an in vitro surrogate to determine the permeability of drugs across cellular membranes. PAMPA at pH 5 was experimentally determined in a dataset of 5,473 unique compounds by the NIH-NCATS. 50% of the dataset was used to train a classifier (SVM) to predict the permeability of new compounds, and validated on the remaining 50% of the data, rendering an AUC = 0.88. The Peff was converted to logarithmic, log Peff value lower than 2.0 were considered to have low to moderate permeability, and those with a value higher than 2.5 were considered as high-permeability compounds. Model Type: Predictive machine learning model. Model Relevance: Predicting compound permeability across cellular membranes. Model Encoded by: Pauline Banye (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos81ew

2024-04-22 | MODEL2404220004 | BioModels

Shah2020 - Predicting liver cytosol stability of small molecules.

Project description:The human liver cytosol stability model is used for predicting the stability of a drug in the cytosol of human liver cells, which is beneficial for identifying potential drug candidates early during the drug discovery process. If a drug compound is quickly absorbed, it may not reach the intended target in the body or become toxic. On the other hand, if a drug compound is too stable, it could accumulate and cause detrimental effects. The authors use an NCATS dataset of 1450 compounds screened in vitro in mouse and human cytosol fractions. Compounds were classified as stable (half-life > 30min) or unstable (half-life ≤ 30 min). Note that authors report the dataset was biased towards stable compounds. Model Type: Machine learning model. Model Relevance: Predicts probability of a compound stability due to liver cells metabolism. Model Encoded by: Pauline (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos9yy1

2024-04-22 | MODEL2404220005 | BioModels

Rahman2022 - High throughput antibacterial screening with machine learning.

Project description:Prediction of antimicrobial potential using a dataset of 29537 compounds screened against the antibiotic resistant pathogen Burkholderia cenocepacia. The model uses the Chemprop Direct Message Passing Neural Network (D-MPNN) and has an AUC score of 0.823 for the test set. It has been used to virtually screen the FDA approved drugs as well as a collection of natural product list (>200k compounds) with hit rates of 26% and 12% respectively. Model Type: Predictive machine learning model. Model Relevance: Probability that a compound inhibits bacterial pathogens with a focus on ESKAPE. Model Encoded by: Sarima Chiorlu (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos5xng

2024-04-22 | MODEL2404080002 | BioModels

Li2021 - HDAC3i-Finder: A Machine Learning-based Computational Tool to Screen for HDAC3 Inhibitors

Project description:The model predicts the inhibitory potential of small molecules against Histone deacetylase 3 (HDAC3), a relevant human target for cancer, inflammation, neurodegenerative diseases and diabetes. The authors have used a dataset of 1098 compounds from ChEMBL and validated the model using the benchmark MUBD-HDAC3. Model Type: Predictive machine learning model. Model Relevance: Probability that the molecule is a HDAC3 inhibitor Model Encoded by: Sarima Chiorlu (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos1n4b

2024-08-06 | MODEL2406210001 | BioModels

Wong2024 - Cytotoxicity Prediction from Human Cell Lines

Project description:The authors use a large dataset (>30k) to train an explainable graph-based model to identify potential antibiotics with low cytotoxicity. The model uses a substructure-based approach to explore the chemical space. Using this method, they were able to screen 283 compounds and identify a candidate active against methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci. Model Type: Predictive machine learning model. Model Relevance: Prediction of Human cytotoxicity endpoints. Model Encoded by: Sarima Chiorlu (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos42ez

2024-05-13 | MODEL2405130002 | BioModels

Shah2020 - Predicting Human Liver Microsomal Stability of small molecules

Project description:The Human Liver Microsomal assay takes into account the liver-mediated drug metabolism to assess the stability of a compound in the human body. The NIH-NCATS group took a proprietary dataset of 4300 compounds with its associated HLM (in vitro half-life; unstable ≤ 30 min, stable >30 min) and used it to train a classifier. Model Type: Machine learning model. Model Relevance: Probability of a compound being unstable in a HLM assay. Model Encoded by: Pauline Banye (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos31ve

2024-05-13 | MODEL2405130005 | BioModels